CEACAM5 and neoplasm: The key clinicopathological features included in this analysis were age at diagnosis, gender, tumor sidedness, stage at diagnosis, histopathologic grade, two-year survival, five-year survival, minimum survival time, body mass index (BMI), glycosylated hemoglobin (%HbA1c), lymphovascular invasion (LVI), perineural invasion (PNI), and circulating carcinoembryonic antigen (CEA) levels.